| Chronic Kidney Disease |
1 |
1 |
| Hemodialysis |
0 |
0.99 |
| Pruritus |
0 |
0.98 |
| Renal Failure |
0 |
0.94 |
| Patient Safety |
0 |
0.45 |
| Dialysis |
0 |
0.35 |
| Adverse Effects |
0 |
0.3 |
| Food and Drug Administration (FDA) |
0 |
0.97 |
| Opioids |
0 |
0.24 |
| Revenue and Practice Management |
0 |
0.22 |
| Receptors |
0 |
0.17 |
| Renal Disease |
0 |
0.17 |
| Clinical Research |
0 |
0.13 |
| Quality of Life |
0 |
0.13 |
| Diarrhea |
0 |
0.12 |
| Emesis |
0 |
0.09 |
| Insurance |
0 |
0.09 |
| Intravenous |
0 |
0.09 |
| Medicare |
0 |
0.09 |
| Cardiovascular Imaging |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| Brachial |
0 |
0.04 |
| Central Nervous System |
0 |
0.04 |
| Dizziness |
0 |
0.04 |
| Echocardiography |
0 |
0.04 |
| Financial Reimbursement |
0 |
0.04 |
| Health Care Quality, Access, and Evaluation |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Medicaid |
0 |
0.04 |
| Sleep |
0 |
0.04 |
| Topical Therapy |
0 |
0.04 |